Nonmyeloablative hematopoietic cell transplantation (HCT) for treatment of patients (pts) with fludarabine-refractory chronic lymphocytic leukemia (CLL) results in prolonged median survival.
暂无分享,去创建一个
J. Radich | R. Storb | B. Sandmaier | D. Maloney | B. Storer | D. Niederwieser | K. Blume | E. Agura | M. Maris | M. Sorror